Recombinant Human Cysteine-rich PAK1 inhibitor (CRIPAK)

ACP19309

Number

Order Exclusive Products Now

Request a Quote

High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications

Cat.No	ACP19309	Target Name	CRIPAK
Target Synonyms	CRIPAKCysteine-rich PAK1 inhibitor; CRIPak	Form	Lyophilized powder
Expression System	Custom Production. Please inquire and provide the desire expression system.	Expression Range	1-446
Protein Length	Full length protein	Purity	>85% (SDS-PAGE)
Storage Buffer	5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information

Target Species	Human	Uniprot ID	Q8N1N5

Background Information

Uniprot Id

Q8N1N5
Target Species

Human
Target Name

CRIPAK
Target Function

Putative negative regulator of PAK1. It has been suggested that the lost of CRIPAK in breast tumors might contribute to hormonal independence.
Target Subcellular Location

Cytoplasm. Membrane. Nucleus. Note=Translocated to the nuclear compartment upon hormonal treatment by estrogen.
Target Tissue Specificity

Widely expressed with a highest expression observed in trachea, prostate and adrenal glands. Expressed in many cancer cell lines including breast cancer cells.
Target Synonyms

CRIPAKCysteine-rich PAK1 inhibitor; CRIPak

Inquire Recombinant Human Cysteine-rich PAK1 inhibitor (CRIPAK) Now

Full Name *

Business Email Address *

Phone

Products/Services

Catalog Number

Quantity (μg, mg, g, μl, ml, L, kit)

Address

Project Description

AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Submit

Recombinant Human Cysteine-rich PAK1 inhibitor (CRIPAK)

Specifications

Immunogen Information

Inquire Recombinant Human Cysteine-rich PAK1 inhibitor (CRIPAK) Now

Related Products